How M.D. was paid
$4.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Lynn Seely, M.D.President, Chief Executive Officer and Director | $690,173 | $186,806 | $2,907,551 | $414,000 | $23,735 | $4,222,265 |
| Stephen HillChief Operating Officer | $529,473 | $62,269 | $1,183,606 | $291,500 | $9,591 | $2,076,439 |
| Gary Lee, Ph.D.Chief Scientific Officer | $520,015 | $62,269 | $1,093,547 | $260,000 | $6,790 | $1,942,621 |
What changed and why
- $4.2MCEO Lynn Seely received total compensation of $4,222,265 in 2025, compared to $1,495,376 in 2024.
- $690KBase salary for Dr. Seely increased to $690,173 in 2025.
- 100%Annual performance bonuses were awarded based on a 100% achievement level of corporate goals.
- Equity compensation in 2025 included a combination of time-based options, performance-based options, and RSUs.
- No discretionary cash bonuses were earned or paid in 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.